Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03582618
Title CVM-1118 and Sorafenib Combination in Subjects With Advanced Hepatocellular Carcinoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors TaiRx, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Charleston Hematology Oncology Associates Charleston South Carolina 29403 United States Details
National Cheng Kung University Hospital Tainan 704 Taiwan Details
National Taiwan University Hospital Taipei 11502 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field